SCYNEXIS Inc (SCYX)
1.77
-0.01
(-0.56%)
USD |
NASDAQ |
May 03, 16:00
1.78
+0.01
(+0.56%)
After-Hours: 20:00
SCYNEXIS Enterprise Value: 4.621M for May 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 4.621M |
| May 02, 2024 | 4.998M |
| May 01, 2024 | 2.733M |
| April 30, 2024 | 1.600M |
| April 29, 2024 | 6.508M |
| April 26, 2024 | -4.063M |
| April 25, 2024 | -6.705M |
| April 24, 2024 | -5.573M |
| April 23, 2024 | -3.685M |
| April 22, 2024 | -7.838M |
| April 19, 2024 | -7.838M |
| April 18, 2024 | -9.159M |
| April 17, 2024 | -8.593M |
| April 16, 2024 | -8.971M |
| April 15, 2024 | -6.705M |
| April 12, 2024 | -7.649M |
| April 11, 2024 | -1.797M |
| April 10, 2024 | -2.552M |
| April 09, 2024 | -0.6648M |
| April 08, 2024 | -0.6648M |
| April 05, 2024 | 2.356M |
| April 04, 2024 | 1.223M |
| April 03, 2024 | 5.753M |
| April 02, 2024 | -7.460M |
| April 01, 2024 | -5.950M |
| Date | Value |
|---|---|
| March 28, 2024 | -6.705M |
| March 27, 2024 | -8.404M |
| March 26, 2024 | -9.726M |
| March 25, 2024 | -8.216M |
| March 22, 2024 | -9.726M |
| March 21, 2024 | -9.348M |
| March 20, 2024 | -8.971M |
| March 19, 2024 | -7.838M |
| March 18, 2024 | -7.838M |
| March 15, 2024 | -7.460M |
| March 14, 2024 | -5.573M |
| March 13, 2024 | -4.440M |
| March 12, 2024 | -1.797M |
| March 11, 2024 | -1.420M |
| March 08, 2024 | 0.4678M |
| March 07, 2024 | 1.600M |
| March 06, 2024 | 0.8453M |
| March 05, 2024 | 0.0903M |
| March 04, 2024 | -0.6648M |
| March 01, 2024 | -1.042M |
| February 29, 2024 | -1.926M |
| February 28, 2024 | 1.050M |
| February 27, 2024 | 1.050M |
| February 26, 2024 | 1.794M |
| February 23, 2024 | 0.3061M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-18.22M
Minimum
Nov 29 2023
127.05M
Maximum
Jan 03 2022
47.39M
Average
48.14M
Median
Oct 21 2019
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 2.813M |
| Palatin Technologies Inc | 24.56M |
| iBio Inc | 16.80M |
| Theriva Biologics Inc | -13.31M |
| Oragenics Inc | 3.216M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -19.59M |
| Revenue (Quarterly) | 5.797M |
| Total Expenses (Quarterly) | 28.86M |
| EPS Diluted (Quarterly) | -0.41 |
| Gross Profit Margin (Quarterly) | -153.3% |
| Profit Margin (Quarterly) | -337.9% |
| Earnings Yield | 73.45% |
| Operating Earnings Yield | 84.87% |
| Normalized Earnings Yield | 78.54 |